Back to Market Feed

Product Information

GNP NAPROXEN SODIUM 220 MG CAP is a generic product labeled by AmerisourceBergen, priced at $0.1507 per EA under NDC 46122078064. Its NADAC has been published 87 times since Dec 25, 2024.

FDA first approved this application on Feb 17, 2006.

GNP NAPROXEN SODIUM 220 MG CAP

Naproxen Sodium
$0.1507per EA
OTC

Strength

220 mg/1

Manufacturer

AmerisourceBergen

NDC

46122078064

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

NAPROXEN SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021920

FDA Approved

2/17/2006

On Market Since

4/11/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for GNP NAPROXEN SODIUM 220 MG CAP has been published 87 times since Dec 25, 2024, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1507 per EA
All-time high$0.1555 (Jan 15, 2025)
All-time low$0.1331 (Jul 23, 2025)
52-week high$0.1513
52-week low$0.1391
Median price$0.1442
Average price$0.1436
Largest weekly change+4.5% (Aug 20, 2025)
Weeks tracked87
Tracking sinceDec 25, 2024

Price History

1W

-0.4%

1M

-0.4%

3M

+2.9%

6M

+4.5%

1Y

+8.4%

3Y

N/A

5Y

N/A

All

-3.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of GNP NAPROXEN SODIUM 220 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for GNP NAPROXEN SODIUM 220 MG CAP, manufactured by AmerisourceBergen, is $0.1507 per EA (NDC 46122078064), effective Aug 19, 2026.

How has the price of GNP NAPROXEN SODIUM 220 MG CAP changed over time?

Over the history we have for it, the NADAC for GNP NAPROXEN SODIUM 220 MG CAP has declined 3.1%. It has been tracked across 87 weekly CMS publications since Dec 25, 2024.

What are the highest and lowest recorded NADAC prices for GNP NAPROXEN SODIUM 220 MG CAP?

Since Dec 25, 2024, the NADAC for GNP NAPROXEN SODIUM 220 MG CAP has ranged from a low of $0.1331 (Jul 23, 2025) to a high of $0.1555 (Jan 15, 2025), with a median of $0.1442 per EA.

Are there cheaper alternatives to GNP NAPROXEN SODIUM 220 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of GNP NAPROXEN SODIUM 220 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GNP NAPROXEN SODIUM 220 MG CAP?

GNP NAPROXEN SODIUM 220 MG CAP (NDC 46122078064) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.